You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for New Drug Application (NDA): 204141


✉ Email this page to a colleague

« Back to Dashboard


NDA 204141 describes TOPICORT, which is a drug marketed by Taro and is included in ten NDAs. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TOPICORT profile page.

The generic ingredient in TOPICORT is desoximetasone. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.
Summary for 204141
Tradename:TOPICORT
Applicant:Taro
Ingredient:desoximetasone
Patents:2
Pharmacology for NDA: 204141
Medical Subject Heading (MeSH) Categories for 204141
Suppliers and Packaging for NDA: 204141
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOPICORT desoximetasone SPRAY;TOPICAL 204141 NDA AUTHORIZED GENERIC Taro Pharmaceuticals U.S.A., Inc. 51672-1396 51672-1396-3 1 BOTTLE, SPRAY in 1 CARTON (51672-1396-3) / 30 mL in 1 BOTTLE, SPRAY
TOPICORT desoximetasone SPRAY;TOPICAL 204141 NDA AUTHORIZED GENERIC Taro Pharmaceuticals U.S.A., Inc. 51672-1396 51672-1396-4 1 BOTTLE, SPRAY in 1 CARTON (51672-1396-4) / 50 mL in 1 BOTTLE, SPRAY

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY;TOPICALStrength0.25%
Approval Date:Apr 11, 2013TE:ATRLD:Yes
Patent:⤷  SubscribePatent Expiration:Sep 1, 2028Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER
Patent:⤷  SubscribePatent Expiration:May 26, 2026Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER

Expired US Patents for NDA 204141

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Taro TOPICORT desoximetasone SPRAY;TOPICAL 204141-001 Apr 11, 2013 ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.